ONE of the dream musical teams of recent years has been India-based singer Zora Randhawa and chart topping British music producer Dr Zeus.
Together the close friends have delivered some super hit songs, including a stunning
collaboration with hip hop legend Snoop Dogg earlier this year.
The duo headlined the recent Newham Under The Stars concert and delivered a blockbuster
performance with a live band. They are looking forward to the release of their next song
Gwandian Da Dhol.
I caught up with Zora to talk about music, working with Dr Zeus and more.
When did you first become connected to music?
I was seven years old when I performed for the first time – it was a school annual function in grade three. My musical influences growing up were Mohd Rafi and Surjit Bindrakhia.
How did you feel at the release of your first song?
I was over the moon and over-excited. (Laughs) I was worried too, but it all worked out.
Which of your songs would you say has given you the greatest joy?
All the songs that I have sung until now have given me different kinds of joy. I have sung eight songs and spent a good three to four months on a single track. So all my songs are really close to my heart.
Can you tell if a song will be a hit in the studio?
Not really, but you can feel the vibes.
You have had amazing successes with Dr Zeus, but what is he like to work with?
It’s a great feeling working with a legendary producer like Dr Zeus. I was always a great fan of his so it was like a dream come true to work with him. Today he is like a brother to me. I think we work together really well because of the chemistry and understanding
we share. (Smiles) We are like jodi number one.
What was it like doing the song Woofer with Zeus and Snoop Dogg?
It was another a dream come true moment for me, working with two of the biggest superstars in the world of music.
How much does performing live mean to you and which of your live concerts has been the most memorable?
I prefer live performances over a PA. I think you get more freedom while performing live. I have done live shows at many places like India, England, Toronto and the experience has been really great every single time.
Which has been the most interesting destination your musical journey has taken you to?
I have been to a lot of places for work, but the experience in Kenya was a crazy one. It was for the wedding of a member of the richest Punjabi families living there, and was great fun.
What is your greatest musical ambition?
I don’t have any ambitions or plans away from music. It is my only focus. I want to keep working hard and leave it in the hands of god, and my fans.
What kind music dominates your play list?
Every type of good music from different genres is in my play list. At times it even depends on my mood and the artists.
Who would you love to collaborate with?
I have been blessed to do some major collaborations in my career so far and have more on the way. You will find out soon.
What are your biggest passions away from music?
(Laughs) I always wanted to be a FBI officer.
Today what inspires you?
My family and fans inspire me most.
If you could ask any artist, alive or dead, a question, who would it be and what would you ask?
I would have asked Michael Jackson to collaborate
with me.
What can we expect from you next?
Another hit with Gwandian Da Dhol.
Finally, why do you love music?
I can’t live without music.
DR ZEUS ON ZORA
“There are plenty of talented artists out there, but very few like Zora, who combine a natural ability with hard work and a hunger to be the best they can. We work well together because both of us want the very best.
“He is also a great human being and has remained grounded despite the global success. He still has the same hunger as when he did with the first track and I think that will remain for a long time to come, and why he will continue delivering hits.
“Also, Zora has been with me through thick and thin, including during hard times, like a
true brother from another mother.”
KAJOL’S FILM GROUNDED
I HAVE never seen Kajol do as much promotion for a movie as she has done with Helicopter Eela.
A few months ago she was giving interviews to everyone ahead of the movie being
released on September 7, but all that seems to have gone to waste because it has been postponed to October 12. The main reason being cited is the ill health of director
Pradeep Sarkar, but if the movie was shot many months ago, why are the filmmakers still doing post production just a few weeks before the release?
I think this will badly damage a movie that was already struggling to get attention and it will be a major misfire when it comes out.
NEHA: WEDDING RUSH
ACTRESS Neha Dhupia shared a heavily pregnant photograph of herself with husband Angad Bedi on social media, but this led to her being bombarded with jokes because she only got married recently.
Most pointed out that the Bollywood star had a surprise wedding in May because most likely she was already expecting.
Shortly after sharing the news, the couple walked the ramp together as showstoppers for fashion designer Payal Singhal at the Lakmé Fashion Week in Mumbai.
JHANVI ON THE CATWALK
RISING star Jhanvi Kapoor followed up her recent Bollywood debut in Dhadak by making her first appearance on the catwalk as a showstopper for designer Nachiket Barve at the Lakmé Fashion Week in Mumbai.
The 21 year-old admitted to being afraid of tripping because the outfit looked heavy, but
was relieved it was light and comfortable when she put it on.
Next up for the daughter of late great star Sridevi is a starring role in Karan Johar’s next directorial outing Takht alongside Ranveer Singh, Kareena Kapoor Khan, Alia Bhatt, Vicky Kaushal, Bhumi Pednekar and Anil Kapoor.
SONAKSHI: NOT SO HAPPY NEWS
ACTRESS Sonakshi Sinha continued her poor run at the box office with her recently released misfire Happy Phirr Bhag Jayegi.
The comedy sequel clocked up low numbers as I expected, and I am beginning to wonder
why she gets so many chances despite her flop films. It seems as if producers haven’t learned their lesson because she has more movies on the way. Those filmmakers
should instead cast television actresses who have bigger fan bases and are more talented
performers.
END OF THE KAPOOR ERA
WHEN late great Bollywood legend Raj Kapoor passed away, he left behind an incredible
empire that included a huge studio complex, massive fortune, a flourishing film banner, palatial house and a phenomenal legacy.
But his three sons Rishi, Randhir and Rajiv Kapoor have all but destroyed that. Film production stopped,they sold off the house their father left his wife, let the studio go into disrepair, lost all the iconic film props in a fire and more. They are now selling the one remaining asset, the studio, despite repeatedly boasting they would resurrect the banner.
When the history of the Kapoors is written, it will tell of how a father built a magnificent
empire and the sons let it fall.
SHAH RUKH DROWNING IN FLOOD OF FAKE NEWS
KERALA has not only had to battle floods, but also fake news stories that have swept across social media.
One obviously false story was that Shah Rukh Khan had personally donated around £550,000 to flood relief in the state, when in fact it was his charity that had handed
over just over £23,000.
Shah Rukh’s die-hard fans were, of course, not willing to believe the truth and were hurling insults despite various media confirming the sum of £550,000 as being fake.
I have been reporting on Shah Rukh since 2001, but have seen more rumours about him this year than the previous 17. All those fans who are spreading false news are harming
a brand the A-list star has worked so hard to build.
NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
The programme aims to support 220,000 people over three years
Eligible patients must have a BMI over 40 and at least four obesity-related health issues
GP leaders raise concerns over increased workload
Pharmacists urge a broader weight management approach
NHS expands obesity treatment with Mounjaro
The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.
Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.
GPs express concern over added burden
While the rollout has been welcomed as a major step in tackling severe obesity, some family doctors have expressed concern over the operational challenges it may bring. The British Medical Association and other GP leaders have highlighted the need for additional training, resources and time to manage the expected rise in patient demand.
They warn that without extra support, the move could add further pressure to already stretched primary care services.
Calls for a comprehensive approach
Pharmacy experts and health professionals have stressed that Mounjaro should not be viewed as a standalone solution. Instead, they argue that it must be integrated into a broader weight management strategy that includes dietary changes, physical activity, and behavioural support.
There are also concerns about potential pressure on drug supplies as demand increases. Experts suggest that clear guidance on prescription protocols and supply management will be crucial to avoid shortages.
A targeted step in tackling obesity
The introduction of Mounjaro is part of the NHS’s wider effort to address rising obesity levels in the UK, which are closely linked to long-term health complications and increased strain on the health system. By targeting the most at-risk individuals, health officials hope the new measure will reduce future hospitalisations and improve overall health outcomes.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
Around 85% of the projected deaths are likely to involve people over the age of 65
Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.
Climate change driving deadly temperatures
Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.
The scientists estimate that human activity has increased the temperatures experienced during this heatwave by 2°C to 4°C, pushing the mercury beyond safe levels for many, particularly the elderly and those with underlying health conditions.
Dr Garyfallos Konstantinoudis from Imperial College London, who helped conduct the analysis, said: “Heatwaves are silent killers – people who lose their lives in them typically have pre-existing health conditions and rarely have heat listed as a contributing cause of death. This real-time analysis reveals the hidden toll of heatwaves, and we want it to help raise the alarm.”
Deaths concentrated among older adults
The analysis, based on decades of UK temperature and mortality data across more than 34,000 locations in England and Wales, projects around 570 excess deaths between Thursday and Sunday. Of these, approximately 129 are expected in London. Scientists believe the figure may be underestimated, as early summer heatwaves often catch people unprepared.
Around 85% of the projected deaths are likely to involve people over the age of 65, who are particularly vulnerable to heat stress. Other at-risk groups include infants, pregnant individuals, and people with cardiovascular or respiratory conditions.
Dr Malcolm Mistry from the London School of Hygiene & Tropical Medicine (LSHTM), who contributed to the study, warned: “Exposure to temperatures in the high 20s or low 30s may not seem dangerous, but they can be fatal, particularly for people aged over 65, infants, pregnant people, and those with pre-existing health conditions.”
Health and emergency services under pressure
The UK Health Security Agency (UKHSA) issued an amber heat-health alert on Thursday, which is set to remain in effect until 9 am on Monday. The warning highlights a risk of increased deaths and severe impacts on health and social care systems.
Medical professionals have reported a rise in heat-related illnesses. Dr Lorna Powell, an urgent care doctor in East London, said: “We are seeing cases of heat exhaustion rising. It can quickly trigger more serious illnesses, as dehydration sets in and the cardiovascular system becomes overwhelmed.”
The UKHSA advises people to stay out of the sun between 11 am and 3 pm, drink plenty of fluids, keep indoor spaces cool, and check in on vulnerable neighbours and family members. Data from a recent study indicates that approximately 80% of UK homes overheat during summer, further exacerbating health risks for residents.
Urban areas face greater risk
City dwellers, especially those in poorly ventilated flats, face higher health risks during heatwaves. Heat becomes trapped in buildings, leading to prolonged exposure, especially at night when outdoor temperatures remain high.
Professor Antonio Gasparrini of LSHTM, another contributor to the analysis, said: “When temperatures push past the limits populations are acclimatised to, excess deaths can increase very rapidly. Every fraction of a degree of warming will cause more hospital admissions and heat deaths, putting more strain on the NHS.”
Poor preparedness criticised
Between 2020 and 2024, more than 10,000 people died in the UK due to heatwaves, according to UKHSA data. Yet in April 2025, the government’s climate advisers criticised the UK’s readiness to deal with extreme heat, calling preparations “inadequate, piecemeal and disjointed”.
Despite growing awareness of climate-related risks, systemic changes to improve resilience, such as retrofitting homes and bolstering healthcare capacity, have been limited.
Government removes barriers to home EV chargers
As part of broader environmental measures, the UK government recently eliminated the requirement for planning permission to install electric vehicle (EV) chargers at homes and businesses. This change is estimated to save an average of £1,100 per installation, according to the Department for Transport, and may aid the shift to low-carbon transport. While unrelated to heatwave policy, the move reflects the government’s push for green infrastructure.
Air quality worsens amid heat
Alongside the heat, a spike in air pollution has raised additional concerns. London has been issued a high ozone pollution alert, with people suffering from respiratory conditions such as asthma advised to avoid outdoor exercise.
Heatwaves becoming more frequent and intense
Global data shows that extreme heat causes more deaths than floods, hurricanes, or earthquakes. According to insurer Swiss Re, heatwaves are responsible for about 500,000 deaths globally each year. “Extreme heat events are more dangerous than natural catastrophes in terms of human lives lost, yet the true cost is only starting to come to light,” said Nina Arquint, chief executive of corporate solutions at Swiss Re.
In 2024, the planet recorded its hottest year on record, driven by climate change and rising emissions. Carbon dioxide levels from fossil fuels continue to increase, pushing the world closer to dangerous temperature thresholds.
A recent report by the UK Climate Change Committee estimates that if global temperatures rise by 2°C above pre-industrial levels, annual heat-related deaths in the UK could exceed 10,000 by 2050.
The scientists behind the current analysis hope that quantifying the hidden human cost of heatwaves will prompt more urgent action to reduce emissions and prepare the UK for a hotter future.
Keep ReadingShow less
In a world still catching up with the truths of trans identity
AS Pride Month sweeps across the world in a blaze of colour, protest and celebration, one Indian voice continues to rise with unwavering authenticity. Ella D’Verma is reshaping narratives as a transgender model, fearless LGBTQ+ advocate and digital content creator with a powerful global following.
In a world still catching up with the truths of trans identity, her visibility has become vital – the embodiment of pride in action. In this exclusive conversation with Eastern Eye, she speaks about her journey, the importance of visibility, self-expression, navigating the fashion industry as a trans model, representation, and her vision for the future.
Pride is about honouring those who came before us and ensuring our stories are not lostInstagram / elladverma
What does Pride Month mean to you?
Given the struggles and hardships the LGBTQ+ community has faced, it is only fair that we take this time to honour our stories. For me, the best part of Pride is the conversations and representation it brings. Even if
it is sometimes reduced to marketing or tokenism, the community is being acknowledged. That visibility helps those who may not have the courage to come out yet feel represented. Pride is about honouring those who came before us and ensuring our stories are not lost.
How did lockdown influence your decision to embrace your identity and share it publicly?
Those were difficult times for everyone, but I was fortunate to have my family around and healthy. Lockdown made me realise the fragility of life. It helped me understand that I no longer wanted to live a lie. Being at home kept me away from school, relatives and opinions – that gave me the space to start expressing myself on social media.
Lockdown made me realise the fragility of lifeInstagram / elladverma
Was there a pivotal moment when you realised the importance of being visible and authentic?
The arts were my escape. Whenever I got on stage, I told myself I was good at what I did, even if I was being bullied or felt uncomfortable at home. But one day, the discomfort with myself became overwhelming – I got on stage and forgot my lines. That had never happened to me before. In that moment, it hit me that hiding my identity was costing me too much. That was the moment I came out to my mum.
What challenges have you faced in the fashion industry as a trans model?
Honestly, a lot of garments are not designed for the average cisgender woman, let alone a transgender woman. With my body type, it is often difficult to find clothes that fit well or make me feel comfortable. It has been a journey of accepting that my body is different and not everyone caters to it. I have had to embrace that as part of my story.
How have you learnt to navigate that space?
It is about trusting yourself, knowing your body and what suits it. I have learnt to speak up when something is not working, whether it is makeup or styling. I know what enhances my features, and that confidence makes a shoot successful. Over time, I have stopped mincing words on set. Feeling confident in how I look is 90 per cent of the job.
How do you feel about being recognised as a model who is transgender versus being labelled a transgender model?
My identity is not something I hide or feel ashamed of – I take pride in it. But I am also aware that it is sacred. I do not feel the need to bring it up unless it is relevant. If a job or campaign centres on that identity, I am happy to speak about it. But when my gender is unnecessarily
highlighted, I draw the line. I am a model who happens to be transgender, not a “transgender model”. Orientation should never come before occupation.
You cannot make meaningful change without representation in mainstream mediaInstagram / elladverma
What can the fashion and content industries do to better support transgender individuals?
Ideally, we need new rules and inclusive product design. But realistically, the most important first step is representation. You cannot make meaningful change without representation in mainstream media. That is how you create space, shift narratives, and make inclusion more than a trend.
How do you take care of your mental well-being in the face of challenges like rejection?
It is an ongoing process – none of us is immune to the pain of rejection. But it is about reminding yourself that your worth does not lie in booking a show, securing a deal, or finding a partner. You are whole in yourself, not in your achievements.
How do you hope transgender representation evolves in the future?
Representation is improving, but often it is still tied to a sense of shock, as if having a trans character is automatically a plot point. What I would love to see is
trans stories being told as simply human stories, not with a “transgender” label attached. The long-term goal is for trans identities to be treated as standard, not sensationalised.
Instagram: @elladverma
Keep ReadingShow less
'The Lancet' and presentations at the American Diabetes Association’s 2025
A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.
Record weight loss from Amycretin injections
Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.
Amycretin, developed by Novo Nordisk, the same pharmaceutical company behind Wegovy and the Type 2 diabetes treatment Ozempic, works by targeting both the GLP-1 and amylin receptors. These receptors help control blood sugar levels and suppress appetite.
Strong results for oral version
In addition to the injectable form, a parallel study explored amycretin in tablet form. Conducted over 12 weeks and involving 144 adults, the trial showed those on the highest daily dose (100mg) lost 13.1 per cent of their body weight – a substantial result for an oral medication over such a short period.
Both studies also reported improvements in metabolic and glycaemic health. The authors wrote that amycretin “effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity”. They called for longer and larger trials to assess long-term safety and optimise the dosing regimen.
Pills could overtake jabs in the future
While the injectable version delivered record weight loss, the promising results from the pill suggest oral treatments could soon rival or even surpass jabs in convenience and effectiveness.
Health experts have described the development of an effective pill as a potential “game-changer” in tackling obesity. Professor Jason Halford, former president of the European Association for the Study of Obesity, said: “They will be easier to produce, store and use, and this should mean they could become more widely available. That would produce a significant impact on the nation’s health.”
Limited NHS rollout as private demand surges
Obesity remains a major issue in the UK, with around two in three adults considered overweight or obese. The NHS is set to begin prescribing GLP-1 injections from late June 2025, although the initial rollout will be limited. Around 220,000 people are expected to be treated through the NHS within the next three years.
Eligibility criteria are strict, covering only the most obese patients with at least four chronic health conditions linked to excess weight. Meanwhile, private use of these medications has surged, with an estimated 1.5 million people in the UK having already purchased jabs like Wegovy.
Wegovy also shows promise at higher doses
Separately, another study presented at the ADA meeting focused on Wegovy (semaglutide), examining the effects of a higher weekly dose of 7.2mg. This led to average weight loss of 20.7 per cent over 72 weeks, up from 13.7 per cent at the standard dose used in earlier trials.
As competition intensifies in the weight-loss drug market, amycretin’s early results, particularly in tablet form, suggest it could play a major role in the future of obesity treatment.
I recently joined the incredible team at the Asian Sports Foundation. It is an honour to work alongside passionate individuals such as Shazia Ali, Harleen Kaur and Angus Martin. Since it was founded by Jug Johal, the Asian Sports Foundation has worked to transform inactivity into active living, promoting better wellbeing and greater representation of Asian communities in sport and physical activity.
This is a cause close to my heart. The undeniable power of sport and movement to improve both physical and mental health cannot be overstated. It is a message I have consistently championed, alongside a commitment to equity and inclusion, which is why I am so excited to contribute to a charity that truly embodies this ethos.
In recent weeks, my conversations with Parkinson’s UK and various Asian community groups about boosting wellbeing through activity have shed light on a critical issue: Parkinson’s is on the rise, yet awareness and support remain limited, especially within South Asian communities. The stories I have heard have been deeply moving and point to a pressing need for change.
One person told me about their family’s experience. “We didn’t know much about Parkinson’s at the time,”
They said – a sentiment echoed by many. There is little information about the condition within the community, and it is often shrouded in stigma. In some circles, it is even viewed as a ‘curse’. The diagnosis came as a devastating blow. “We were shocked. All our dreams and plans to see the world came crashing down.” Their honesty reflects the profound emotional impact and isolation many families face.
For those unfamiliar, Parkinson’s is a complex, progressive brain condition. It is the fastest-growing neurological condition in the world, affecting around 153,000 people in the UK. With over 40 symptoms – ranging from tremors and pain to anxiety – and no known cure, the challenges are immense. But staying active and connected can make a real difference.
Parkinson’s is a complex, progressive brain conditionInstagram/ itsmitamistry
This is where organisations like Parkinson’s UK are so vital. They support people at every stage of the Parkinson’s journey, and their efforts to raise awareness in marginalised and ethnic communities are commendable. Their work builds on a strong foundation, which includes local events, essential support services and a pioneering Race Equality in Research programme, aimed at improving understanding and treatment across all communities.
My aim – and a key focus for the Asian Sports Foundation – is to amplify these efforts through inclusive, impactful programmes. We want to act as a bridge, connecting communities with the support and information they need. If you or someone you know is
experiencing symptoms, please know that you are not alone. The journey can be overwhelming, but there are people who care and resources that can help.
I would genuinely love to hear from you. Share your experiences, tell me how we can help, and if you are part of a grassroots community group, let us work together to break the silence and build a more informed, supportive environment for all.